Skip to Content

Aimovig Side Effects

Generic Name: erenumab

Note: This document contains side effect information about erenumab. Some of the dosage forms listed on this page may not apply to the brand name Aimovig.

For the Consumer

Applies to erenumab: subcutaneous solution

Along with its needed effects, erenumab (the active ingredient contained in Aimovig) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Some side effects of erenumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More Common

  • Bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site

Less Common

For Healthcare Professionals

Applies to erenumab: subcutaneous solution

General

The more commonly reported adverse reactions have included injection site reactions and constipation.[Ref]

Hypersensitivity

Postmarketing reports: Hypersensitivity reactions including rash, angioedema, and anaphylaxis

Local

Common (1% to 10%): Injection site reactions

Frequency not reported: Injection site erythema, injection site pruritus, injection site pain

Injection site reactions included reports such as injection site pain and injection site erythema. Injection site reactions were reported in 6%, 5%, and 3% of patients receiving 70 mg/month, 140 mg/month, and placebo, respectively.

Gastrointestinal

Common (1% to 10%): Constipation

Musculoskeletal

Common (1% to 10%): Cramps, muscle spasms

Other

Common (1% to 10%): Fatigue

Dermatologic

Common (1% to 10%): Pruritus

References

1. "Product Information. Aimovig (erenumab)." Amgen USA, Thousand Oaks, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Related questions

Hide